Optimising therapy

How might we treat patients with type 2 diabetes and kidney disease in the future?  What brings us forward is going deeper. That is certainly true in Professor Hiddo Heerspink’s area of research: optimising therapy for people living with type 2 diabetes and kidney disease. The Netherlands-based clinical pharmacologist presents what he believes is going to move the therapeutic needle for this patient group. Watch the episode below to uncover what research questions he is addressing, setting steps towards a more individualised therapy.